Clal Insurance Enterprises (CLIS) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
10 Nov, 2026Executive summary
H1 2024 net income was NIS 257m versus a NIS 80m loss; comprehensive income was NIS 323m versus NIS 55m.
Higher insurance underwriting income and credit-card results supported earnings, while investment returns and life-insurance financial margins were weaker YoY.
AUM rose 3.5% from December 2023 to NIS 350b; premiums, benefit contributions and investment-contract proceeds fell 3% YoY to NIS 13.0b.
Financial highlights
H1 total income was NIS 11.870b versus NIS 11.097b; income before tax was NIS 393m versus a NIS 129m loss, and net income was NIS 257m versus a NIS 80m loss.
Q2 total income was NIS 4.334b versus NIS 7.016b; income before tax was NIS 315m versus NIS 12m, and net income was NIS 215m versus NIS 8m.
H1 gross premiums earned were NIS 5.321b versus NIS 5.707b; credit-card transaction income was NIS 735m versus NIS 367m, with Max consolidated from April 2023.
H1 EPS was NIS 3.22 versus a NIS 1.07 loss; Q2 EPS was NIS 2.70 versus NIS 0.09.
H1 tax expense included a one-off NIS 18m increase from closing prior-year assessments; Max’s effective tax rate was 28.6% versus 23.7%.
Outlook and guidance
No earnings guidance was set; the war’s duration and full effects on economic activity, markets and borrowers’ repayment capacity remained difficult to assess.
The Bank of Israel forecast GDP growth of 1.5% in 2024 and 4.2% in 2025, assuming fighting’s direct economic effect continued through early 2025.
Variable management fees remained suspended until participating-policy returns recover accumulated losses; the related policyholder liability was NIS 0.5b at June 30.
A solvency-report framework expected from December 2024 would include fair value of future variable management fees, estimated to add ~14 percentage points without Transitional Provisions and ~9 points with them.
Long-term savings growth was supported by rising pension contributions, while executive insurance and investment-contract proceeds continued to run off.
Latest events from Clal Insurance Enterprises
- Markets and P&C gains restored profitability, while health reserves and war uncertainty weighed.CLIS
Q1 2024 - 9M comprehensive income reached NIS 596m, supported by stronger investment returns and underwriting.CLIS
Q3 2024 - 2024 comprehensive income rose to NIS 956m as insurance and MAX expanded earnings.CLIS
Q4 2024 - Q1 earnings rose on stronger underwriting and Max, amid market and war-related uncertainty.CLIS
Q1 2025 - H1 core income rose modestly as strong insurance results met Q2 softness and a VAT provision.CLIS
Q2 2025 - 9M earnings and AUM grew, with results absorbing a one-off VAT provision.CLIS
Q3 2025 - Core income rose 12%; 2025 dividend reached NIS 400M.CLIS
Q4 2025 - Core income rose 13% as insurance and savings growth lifted Q1 results.CLIS
Q1 2026 - H1 earnings and AUM grew, alongside NIS 200M buyback and dividend plans.CLIS
Q2 2026